Innoviva, Inc. (INVA) has a market capitalization of $1.56B and trades at $24.19. The 52-week range is 16.52-25.15.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 6, Earnings Per Share (EPS) of $4.02, annual revenue of $425.13M.
The stock has a beta of 0.40, operates in the Healthcare sector.
